University of California (San Francisco) Program

The program in Hematology and Medical Oncology at the University of California, San Francisco (UCSF) is designed to provide fellows with a comprehensive education that integrates clinical training, cutting-edge research, and patient care practices to develop leaders in the field of hematology and oncology. The fellowship is particularly distinguished by its unique features rooted in a longstanding commitment to improving treatment for cancer and blood disorders.

Training Environment and Faculty

The program operates within the UCSF Health system, which includes UCSF Medical Center at Parnassus, UCSF Medical Center at Mount Zion, Zuckerberg San Francisco General Hospital, and the San Francisco Veterans Affairs Medical Center. This diverse training environment allows fellows to gain firsthand experience in various clinical settings and patient populations. The faculty involved in the program consists of renowned specialists who are leaders in their fields, focusing on both clinical excellence and transformative research initiatives 1.

Curriculum Overview

The fellowship is structured into two primary tracks: the classical hematology track and the hematology/oncology track. Each fellow that enters the program can expect a thorough training curriculum divided between clinical practice and research opportunities. The classical hematology track focuses on hematology fellowship training that includes clinical and laboratory experiences guided by a robust mentorship model 3. Fellows pursuing the hematology/oncology track will transition through substantial inpatient and outpatient rotations lasting from 12 to 18 months tailored to individual interests 9.

Clinical Training

Clinical rotations span across all fundamental areas of hematology and oncology, including:

• Inpatient non-malignant hematology
• Inpatient malignant hematology and stem cell transplant
• Inpatient oncology
• Outpatient clinical settings

Fellows will also maintain continuity clinics where they manage a panel of patients for 6 months, ensuring they build long-term therapeutic relationships and comprehensive patient care skills 8.

Didactic Sessions

The educational framework also includes various didactic sessions such as:

• Weekly didactic conferences and division conferences to discuss cases and recent literature
• Monthly fellows research conferences to cultivate ongoing research interests
• Special seminars and tumor boards focused on collaborative decision-making in complex cases

These structured learning experiences emphasize foundational knowledge and advanced concepts necessary for board examinations and clinical competences 7.

Research Opportunities

Research is an integral component of the UCSF Hematology and Oncology program. Each fellow is provided with a minimum of 18 months of protected research time. During this period, fellows are encouraged to engage in groundbreaking studies that span topics such as cellular therapies and novel treatment modalities for hematologic diseases. The program allows fellows to pursue interests in clinical, translational, or laboratory research with faculty mentorship 10.

Research Resources

Affiliated research facilities contribute to a rich environment for scientific exploration, including:

• Helen Diller Family Comprehensive Cancer Center
• Clinical and Translational Science Institute
• Parker Institute for Cancer Immunotherapy

These resources empower trainees to engage in pioneering research initiatives, providing necessary infrastructure, technology, and collaborative opportunities 6.

Application and Competitiveness

The program maintains a competitive selection process, receiving around 400 applications for only 5-7 positions annually. Applicants from various backgrounds, including international medical graduates (IMGs), are welcomed, though candidates must demonstrate U.S. clinical experience 5. The program is known to be friendly to both DO and IMG applicants, with attention given to diversity and inclusion in recruitment 4.

Specific application requirements include the completion of USMLE Parts I, II, and III, and a J-1 visa or U.S. citizenship status. The program generally accepts H-1B visas on a limited basis for qualified candidates 12.

Patient Care Commitment

UCSF's Hematology and Oncology program emphasizes patient-centered care driven by a commitment to improving the quality of life for patients. The fellowship includes experience with regular, interdisciplinary tumor boards that enhance collaborative treatment planning, ultimately translating advanced research into practice 11.